Form D — Savannah Therapeutics, Inc
0002149298-26-000001 · filed Sep 11, 2026
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $6,000,000
- Total sold
- $3,855,000
- Minimum investment
- $25,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Savannah Therapeutics, Inc
- CIK
- 2149298
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 5650 Rivertech Court
Riverdale, MD 20737 - Phone
- 6514910507
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas Wollan · Executive OfficerEdina, MN Find on LinkedIn ↗
-
Matthew Dowling · DirectorBaltimore, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗